These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 33173407)

  • 1. Harnessing real-world evidence to reduce the burden of noncommunicable disease: health information technology and innovation to generate insights.
    Zou KH; Li JZ; Salem LA; Imperato J; Edwards J; Ray A
    Health Serv Outcomes Res Methodol; 2021; 21(1):8-20. PubMed ID: 33173407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Real-world data: a comprehensive literature review on the barriers, challenges, and opportunities associated with their inclusion in the health technology assessment process.
    Zisis K; Pavi E; Geitona M; Athanasakis K
    J Pharm Pharm Sci; 2024; 27():12302. PubMed ID: 38481726
    [No Abstract]   [Full Text] [Related]  

  • 3. Use of Clinical Data Interchange Standards Consortium (CDISC) Standards for Real-world Data: Expert Perspectives From a Qualitative Delphi Survey.
    Facile R; Muhlbradt EE; Gong M; Li Q; Popat V; Pétavy F; Cornet R; Ruan Y; Koide D; Saito TI; Hume S; Rockhold F; Bao W; Dubman S; Jauregui Wurst B
    JMIR Med Inform; 2022 Jan; 10(1):e30363. PubMed ID: 35084343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Noncommunicable Disease Prevention and Control in Mongolia: A Policy Analysis.
    Chimeddamba O; Peeters A; Walls HL; Joyce C
    BMC Public Health; 2015 Jul; 15():660. PubMed ID: 26169789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Burden of non-communicable diseases from infectious causes in 2017: a modelling study.
    Coates MM; Kintu A; Gupta N; Wroe EB; Adler AJ; Kwan GF; Park PH; Rajbhandari R; Byrne AL; Casey DC; Bukhman G
    Lancet Glob Health; 2020 Dec; 8(12):e1489-e1498. PubMed ID: 33098769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Real-world data for health technology assessment for reimbursement decisions in Asia: current landscape and a way forward.
    Lou J; Kc S; Toh KY; Dabak S; Adler A; Ahn J; Bayani DBS; Chan K; Choiphel D; Chua B; Genuino AJ; Guerrero AM; Kearney B; Lin LW; Liu Y; Nakamura R; Pearce F; Prinja S; Pwu RF; Shafie AA; Sui B; Suwantika A; Teerawattananon Y; Tunis S; Wu HM; Zalcberg J; Zhao K; Isaranuwatchai W; Wee HL
    Int J Technol Assess Health Care; 2020 Oct; 36(5):474-480. PubMed ID: 32928330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maximizing the Value of Real-World Data and Real-World Evidence to Accelerate Healthcare Transformation in China: Summary of External Advisory Committee Meetings.
    Sun F; Bedenkov A; Liu BC; Yang J; Xu JF; Ji L; Zhou M; Zhang S; Li X; Song Y; Chen P; Moreno C
    Pharmaceut Med; 2024 May; 38(3):157-166. PubMed ID: 38573457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Data Governance for Real-World Data Management: A Proposal for a Checklist to Support Decision Making.
    Solà-Morales O; Sigurðardóttir K; Akehurst R; Murphy LA; Mestre-Ferrandiz J; Cunningham D; de Pouvourville G
    Value Health; 2023 Apr; 26(4S):32-42. PubMed ID: 36870678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surveillance of Noncommunicable Disease Epidemic Through the Integrated Noncommunicable Disease Collaborative Management System: Feasibility Pilot Study Conducted in the City of Ningbo, China.
    Li S; Zhang L; Liu S; Hubbard R; Li H
    J Med Internet Res; 2020 Jul; 22(7):e17340. PubMed ID: 32706706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current Status, Challenges, and Future Perspectives of Real-World Data and Real-World Evidence in Japan.
    Hiramatsu K; Barrett A; Miyata Y;
    Drugs Real World Outcomes; 2021 Dec; 8(4):459-480. PubMed ID: 34148219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integration of real-world evidence from different data sources in health technology assessment.
    Graili P; Guertin JR; Chan KKW; Tadrous M
    J Pharm Pharm Sci; 2023; 26():11460. PubMed ID: 37529633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Real world evidence (RWE) - a disruptive innovation or the quiet evolution of medical evidence generation?
    Khosla S; White R; Medina J; Ouwens M; Emmas C; Koder T; Male G; Leonard S
    F1000Res; 2018; 7():111. PubMed ID: 30026923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trends in premature avertable mortality from non-communicable diseases for 195 countries and territories, 1990-2017: a population-based study.
    Martinez R; Lloyd-Sherlock P; Soliz P; Ebrahim S; Vega E; Ordunez P; McKee M
    Lancet Glob Health; 2020 Apr; 8(4):e511-e523. PubMed ID: 32199120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conducting real-world evidence studies in India.
    Bhatt A
    Perspect Clin Res; 2019; 10(2):51-56. PubMed ID: 31008069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multi-sectoral action for addressing social determinants of noncommunicable diseases and mainstreaming health promotion in national health programmes in India.
    Arora M; Chauhan K; John S; Mukhopadhyay A
    Indian J Community Med; 2011 Dec; 36(Suppl 1):S43-9. PubMed ID: 22628911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The International Society for Behavioral Medicine (ISBM) and the Society of Behavioral Medicine (SBM) advocate for the inclusion of behavioral scientists in the implementation of the Global Action Plan for the prevention of non-communicable diseases (NCDs) in low- and middle-income countries.
    Odukoya O; Fox RS; Hayman LL; Penedo FJ
    Transl Behav Med; 2021 Jun; 11(6):1286-1288. PubMed ID: 33410489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Real-world evidence: perspectives on challenges, value, and alignment of regulatory and national health technology assessment data collection requirements.
    Sievers H; Joos A; Hiligsmann M
    Int J Technol Assess Health Care; 2021 Feb; 37():e40. PubMed ID: 33622423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aging and the Rising Burden of Noncommunicable Diseases in Sub-Saharan Africa and other Low- and Middle-Income Countries: A Call for Holistic Action.
    Gyasi RM; Phillips DR
    Gerontologist; 2020 Jul; 60(5):806-811. PubMed ID: 31322656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Real-world evidence and product development: Opportunities, challenges and risk mitigation.
    Naidoo P; Bouharati C; Rambiritch V; Jose N; Karamchand S; Chilton R; Leisegang R
    Wien Klin Wochenschr; 2021 Aug; 133(15-16):840-846. PubMed ID: 33837463
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.